Reply

Hepatology

Volumn 49, Issue 2, 2009, Pages 705-

  Papatheodoridis, George V ^a   Manesis, Emanuel K ^a   Manolakopoulos, Spilios ^a   Elefsiniotis, Ioannis S ^b   Goulis, John ^c   Archimandritis, Athanasios J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HELENA VENIZELOU HOSPITAL   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; DISEASE CARRIER; DISEASE CLASSIFICATION; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LETTER; LIVER BIOPSY; LIVER FIBROSIS; PRIORITY JOURNAL;

EID: 67349089491     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22780     Document Type: Letter

References (10)

1. Manesis E, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with HBeAg-negative chronic hepatitis B virus infection. Am J Gastroenterol 203;98:2261-2267.
2. Papatheodotidis GV, Chrysanthos N, Hadziyannis E, Cholongitas E, Manesis EK. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection. J Viral Hepat 2008;15:434-441.
3. Papatheodoridis GV, Manesis EK, Manolakopoulos S, Archimandritis AJ. Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigennegative chronic hepatitis B virus infection. HEPATOLOGY 2007;46: 606-607.
4. Lok ASF, McMahon BJ. Chronic hepatitis B. HEPATOLOGY 2007;45:507-59.
5. European Association for the Study of the Liver. EASL clinical practice guidelines: Management of chronic hepatitis B. J Hepatol 2008; doi: 10.1016/j.jhep.2008.11.012.
6. Kumar M, Satin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008;134:1376-1384.
7. Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol 2007;47:760-767.
8. Lin CL, Liao LY, Liu CJ, Yu MW, Chen PJ, Lai MY, et al. Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels. HEPATOLOGY 2007;45:1193-1198.
9. Martinot-Peignoux M, Boyer N, Colombat M, Akremi R, Pham B-N, Ollivier S, et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002;36:543-548.
10. Feld JJ, Ayers M, El-Ashry D, Mazzulli T, Tellier R, Heathcote EJ. Hepatitis B virus DNA predicdon rules for hepatitis B e antigen-negative chronic hepatitis B. HEPATOLOGY 2007;46:1057-1070.